ACM vs PAC

ACM's Piotroski F-Score of 5/9 indicates stable financial health, though the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to both the Graham Number ($44.91) and intrinsic value ($33.18), currently priced at $97.08, suggesting overvaluation. Despite solid ROE of 28.09% and a history of consistent earnings beats (22 of 25 quarters), recent YoY earnings decline (-29.10%) and insider selling raise concerns. Analysts maintain a 'buy' recommendation with a $130.33 target, implying 24% upside, but weak technical trend (0/100) and bearish insider activity temper near-term optimism.

PAC presents a dichotomy between elite operational profitability and concerning top-line contraction. The deterministic baseline shows a stable Piotroski F-Score of 6/9, though the Graham Number ($7.19) is irrelevant due to an extreme Price-to-Book ratio (1250.27), indicating the company is valued on growth and cash flow rather than assets. While the intrinsic value of $336.6 suggests significant upside, the current bearish technical trend (0/100) and negative YoY revenue growth (-20.60%) offset the strong margins and analyst 'buy' recommendations.